Brazilian study reveals new pathways for preventing atrial fibrillation

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and treating atrial fibrillation, a condition that significantly raises the risks of stroke and dementia.

Meta Title: “Atrium Health Patent: Cancer Treatment with Antibodies & Engineered Cells

Share this article According to GlobalData’s company profile on Atrium Health, was a key innovation area identified from patents. Atrium Health‘s grant share as of

April 15, 2024

Dupixent set for FDA review in adolescent chronic inflammatory sinus disease – Pharmaceutical Technology

The FDA has set a target date of 15 September 2024, four months ahead of the normal review schedule as per priority review benefits. Image

May 13, 2024

Orbitofrontal cortex holds clues for understanding and preventing depression

New research published in JCCP Advances indicates that experiencing negative life events (NLE) during childhood is linked with a higher risk of developing symptoms of

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.